Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio C Chavez

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Expert Opinion on Biological Therapy|September 18, 2024
Recent developments in CD19-targeted therapies for follicular lymphomaAditi Saha, Julio C Chavez
Med (New York, N.Y.)|May 9, 2026
Building on CD19 based therapy for relapse or refractory follicular lymphomaKhushali Jhaveri, Julio C Chavez
Current Treatment Options in Oncology|October 26, 2021
How to Sequence Therapies in Diffuse Large B-Cell Lymphoma Post-CAR-T Cell FailureJennifer M Logue, Julio C Chavez
Best Practice & Research. Clinical Haematology|June 19, 2018
CAR T cell therapy for B-cell lymphomasJulio C Chavez, Frederick L Locke
Therapeutic Advances in Hematology|June 9, 2021
The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphomaJose Sandoval-Sus, Julio C Chavez
Blood|March 28, 2015
Life after ibrutinib? A new unmet need in CLLJavier Pinilla-Ibarz, Julio C Chavez
Drugs in Context|October 4, 2021
Bispecific antibodies for non-Hodgkin's lymphomas and multiple myelomaOmar Castaneda-Puglianini, Julio C Chavez
Journal of Blood Medicine|September 1, 2021
Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell LymphomaOmar Castaneda-Puglianini, Julio C Chavez
Seminars in Hematology|September 21, 2024
CARs Moving Forward: The Development of CAR T-Cell Therapy in the Earlier Treatment Course of Hematologic MalignanciesOmar Castaneda Puglianini, Julio C Chavez
Drugs in Context|December 18, 2019
Drug therapy for double-hit lymphomaVania Phuoc, Jose Sandoval-Sus, Julio C Chavez
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Expert Opinion on Biological Therapy|September 18, 2024
Recent developments in CD19-targeted therapies for follicular lymphomaAditi Saha, Julio C Chavez
Med (New York, N.Y.)|May 9, 2026
Building on CD19 based therapy for relapse or refractory follicular lymphomaKhushali Jhaveri, Julio C Chavez
Current Treatment Options in Oncology|October 26, 2021
How to Sequence Therapies in Diffuse Large B-Cell Lymphoma Post-CAR-T Cell FailureJennifer M Logue, Julio C Chavez
Best Practice & Research. Clinical Haematology|June 19, 2018
CAR T cell therapy for B-cell lymphomasJulio C Chavez, Frederick L Locke
Therapeutic Advances in Hematology|June 9, 2021
The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphomaJose Sandoval-Sus, Julio C Chavez
Blood|March 28, 2015
Life after ibrutinib? A new unmet need in CLLJavier Pinilla-Ibarz, Julio C Chavez
Drugs in Context|October 4, 2021
Bispecific antibodies for non-Hodgkin's lymphomas and multiple myelomaOmar Castaneda-Puglianini, Julio C Chavez
Journal of Blood Medicine|September 1, 2021
Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell LymphomaOmar Castaneda-Puglianini, Julio C Chavez
Seminars in Hematology|September 21, 2024
CARs Moving Forward: The Development of CAR T-Cell Therapy in the Earlier Treatment Course of Hematologic MalignanciesOmar Castaneda Puglianini, Julio C Chavez
Drugs in Context|December 18, 2019
Drug therapy for double-hit lymphomaVania Phuoc, Jose Sandoval-Sus, Julio C Chavez
Pageof 14